Research has found that individuals over the age of 45 who treated their Type 2 diabetes with anti-hyperglycemic drugs had a greater multiple sclerosis risk, especially in women, while individuals under the age of 45 using anti-hyperglycemic exposure had a lower risk.…
0 Comments